News & Analysis on Clinical Trial Services & Contract Research And Development
FIT Biotech has entered into a partnership that will see its GTU MultiHIV DNA plasmid developed using ImmunoVaccine Technologies’ DepoVax delivery tool, which uses liposomes to encapsulate a target antigen and adjuvant.
At BIO 2009 Cobra Biomanufacturing explained to Outsourcing-Pharma its maxXpress service, its thoughts on expanding to commercial scale and the recent deal with KAHR Medical.
Biotechs use smaller CROs as much as larger service providers and regard patient recruitment speed as by far the most important characteristic, according to a report.
Sanofi Pasteur has landed what it believes will be the first of a series of orders from the US Department of Health and Human Services (HHS) to produce H1N1 vaccines.
There has been “tremendous interest” in Fate Therapeutics’ Catalyst programme, which gives access to induced iPS cell technology as part of collaborative relationship between numerous companies.